Dr. Maximilian Merz, MD is an oncologist in Commack, NY specializing in adult oncology and adult hematology. He graduated from Heidelberg University. Dr. Maximilian Merz, MD is affiliated with Memorial Sloan Kettering Cancer Center.
Dr. Maximilian Merz, MD graduated from Heidelberg University. He completed residency at Department of Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Germany. He is certified by the Board Certification: Internal Medicine, Hematology and Oncology and has a state license in New York.
Medical School: Heidelberg University
Residency: Department of Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Germany
Board Certification: Board Certification: Internal Medicine, Hematology and Oncology
Licensed In: New York
Dr. Maximilian Merz, MD appears to accept the following insurance providers: Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO), Magnacare, Emblem, Oscar, Fidelis, NYC Medicare Advantage Plus for City Employees, Healthsmart, Aetna, United Healthcare, Tricare, Oxford, Healthfirst, Husky CT Medicaid, Cigna, Qualcare, MVP, Connecticare, Healthfirst Medicare Advantage, First Health, Multiplan/Beech Street/PHCS, World Trade Center Health Program (WTC), Blue Cross Blue Shield states outside of NY/NJ, Empire Essential, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, Blue Cross Blue Shield Federal Employee Program, UMR, Medicare Part A&B (traditional Medicare), Carrum Health and Blue Cross Health Plus.
According to our sources, Dr. Maximilian Merz, MD accepts the following insurance providers:
Dr. Maximilian Merz, MD has an exceptional overall rating with an average of 4.99 out of 5 stars based on 167 ratings. We collect ratings and reviews of Dr. Maximilian Merz, MD from all over the web to help you find the right in Commack, NY.
I am a multiple myeloma specialist and board-certified hematologist-oncologist at Memorial Sloan Kettering Cancer Center (MSK) in New York. I specialize in the diagnosis and treatment of people with acute and chronic leukemias, and Hodgkin and non-Hodgkin lymphomas, with a major emphasis on multiple myeloma. I am an expert in CAR T cell therapy, autologous and allogeneic transplantation, as well as caring for patients with blood cancers in the hospital and the clinic.